Amy C Justice

Author PubWeight™ 270.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009 19.90
2 Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002 16.56
3 Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 2009 14.01
4 HIV infection and the risk of acute myocardial infarction. JAMA Intern Med 2013 5.90
5 HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis. Lancet 2006 5.00
6 Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis 2008 4.46
7 Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS 2007 4.31
8 Development and verification of a "virtual" cohort using the National VA Health Information System. Med Care 2006 4.28
9 Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis 2010 3.72
10 Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol 2007 3.46
11 A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcohol Clin Exp Res 2005 3.21
12 Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis 2007 3.02
13 HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med 2010 3.00
14 HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr 2012 2.95
15 Increased COPD among HIV-positive compared to HIV-negative veterans. Chest 2006 2.93
16 The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med 2005 2.58
17 Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and HIV/HCV-co-infected veterans. AIDS 2005 2.56
18 Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis 2012 2.50
19 Estimating the proportion of patients infected with HIV who will die of comorbid diseases. Am J Med 2005 2.38
20 Rate and predictors of treatment prescription for hepatitis C. Gut 2006 2.31
21 Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy. Stat Med 2004 2.26
22 Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies. AIDS 2007 2.24
23 Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients. Clin Infect Dis 2014 2.24
24 U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med 2012 2.18
25 Understanding racial disparities in HIV using data from the veterans aging cohort 3-site study and VA administrative data. Am J Public Health 2003 2.16
26 How harmful is hazardous alcohol use and abuse in HIV infection: do health care providers know who is at risk? J Acquir Immune Defic Syndr 2003 2.14
27 Increased risk of fragility fractures among HIV infected compared to uninfected male veterans. PLoS One 2011 2.11
28 Hepatitis C treatment completion rates in routine clinical care. Liver Int 2009 2.10
29 HIV infection and the risk of diabetes mellitus. AIDS 2009 2.10
30 The payoff time: a flexible framework to help clinicians decide when patients with comorbid disease are not likely to benefit from practice guidelines. Med Care 2009 2.10
31 Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis 2009 2.10
32 Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression. J Acquir Immune Defic Syndr 2009 2.09
33 Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease. Arch Intern Med 2011 2.08
34 Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis 2009 2.05
35 Spirituality and religion in patients with HIV/AIDS. J Gen Intern Med 2006 1.99
36 Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection. Hepatology 2004 1.97
37 A framework for tailoring clinical guidelines to comorbidity at the point of care. Arch Intern Med 2007 1.92
38 Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med 2015 1.86
39 Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies. Antivir Ther 2008 1.83
40 Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study. Pharmacoepidemiol Drug Saf 2011 1.76
41 Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans. AIDS Educ Prev 2009 1.72
42 Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era. Crit Care Med 2013 1.71
43 Validating smoking data from the Veteran's Affairs Health Factors dataset, an electronic data source. Nicotine Tob Res 2011 1.69
44 An internationally generalizable risk index for mortality after one year of antiretroviral therapy. AIDS 2013 1.64
45 Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study. Ann Intern Med 2014 1.64
46 Impact of pneumococcal vaccination on the incidence of pneumonia by HIV infection status among patients enrolled in the Veterans Aging Cohort 5-Site Study. Clin Infect Dis 2008 1.62
47 The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C. Circ Cardiovasc Qual Outcomes 2011 1.62
48 Clinical importance of HIV and depressive symptoms among veterans with HIV infection. J Gen Intern Med 2002 1.57
49 Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model. Ann Intern Med 2008 1.55
50 Do benefits of earlier antiretroviral treatment initiation outweigh harms for individuals at risk for poor adherence? Clin Infect Dis 2009 1.54
51 Management of human immunodeficiency virus infection in advanced age. JAMA 2013 1.51
52 Long-term HIV/AIDS survival estimation in the highly active antiretroviral therapy era. Med Decis Making 2003 1.49
53 How does depression influence diabetes medication adherence in older patients? Am J Geriatr Psychiatry 2005 1.46
54 Hepatocellular carcinoma and non-Hodgkin's lymphoma: the roles of HIV, hepatitis C infection, and alcohol abuse. J Clin Oncol 2006 1.44
55 Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. AIDS 2015 1.44
56 Alcohol problems and health care services use in human immunodeficiency virus (HIV)-infected and HIV-uninfected veterans. Med Care 2006 1.41
57 Association of age and comorbidity with physical function in HIV-infected and uninfected patients: results from the Veterans Aging Cohort Study. AIDS Patient Care STDS 2011 1.37
58 Food insecurity is associated with poor virologic response among HIV-infected patients receiving antiretroviral medications. J Gen Intern Med 2011 1.37
59 Virologic and immunologic response to HAART, by age and regimen class. AIDS 2010 1.34
60 Differences between infectious diseases-certified physicians and general medicine-certified physicians in the level of comfort with providing primary care to patients. Clin Infect Dis 2005 1.33
61 The burden of illness in the first year home: do male and female VA users differ in health conditions and healthcare utilization. Womens Health Issues 2010 1.33
62 Delayed presentation for human immunodeficiency virus (HIV) care among veterans: a problem of access or screening? Med Care 2007 1.32
63 The next therapeutic challenge in HIV: polypharmacy. Drugs Aging 2013 1.30
64 Testing, referral, and treatment patterns for hepatitis C virus coinfection in a cohort of veterans with human immunodeficiency virus infection. Clin Infect Dis 2003 1.29
65 Treatment outcomes of a stage 1 cognitive-behavioral trial to reduce alcohol use among human immunodeficiency virus-infected out-patients in western Kenya. Addiction 2011 1.29
66 Role of alcohol in determining human immunodeficiency virus (HIV)-relevant outcomes: A conceptual model to guide the implementation of evidence-based interventions into practice. Med Care 2006 1.28
67 Effect of persistent moderate viremia on disease progression during HIV therapy. J Acquir Immune Defic Syndr 2004 1.27
68 Physiologic frailty and fragility fracture in HIV-infected male veterans. Clin Infect Dis 2013 1.26
69 The association between alcohol consumption and prevalent cardiovascular diseases among HIV-infected and HIV-uninfected men. J Acquir Immune Defic Syndr 2010 1.25
70 Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery. Clin Infect Dis 2014 1.25
71 Risk factors for hospitalization and medical intensive care unit (MICU) admission among HIV-infected Veterans. J Acquir Immune Defic Syndr 2013 1.23
72 Patterns of drug use and abuse among aging adults with and without HIV: a latent class analysis of a US Veteran cohort. Drug Alcohol Depend 2010 1.23
73 Adjusting alcohol quantity for mean consumption and intoxication threshold improves prediction of nonadherence in HIV patients and HIV-negative controls. Alcohol Clin Exp Res 2008 1.23
74 Differences in symptom expression in older HIV-positive patients: The Veterans Aging Cohort 3 Site Study and HIV Cost and Service Utilization Study experience. J Acquir Immune Defic Syndr 2003 1.21
75 Decreased awareness of current smoking among health care providers of HIV-positive compared to HIV-negative veterans. J Gen Intern Med 2007 1.19
76 Association of venous thromboembolism with human immunodeficiency virus and mortality in veterans. Am J Med 2004 1.19
77 An experimental study of the agreement of self-administration and telephone administration of the Timeline Followback interview. J Stud Alcohol Drugs 2008 1.18
78 Measuring performance directly using the veterans health administration electronic medical record: a comparison with external peer review. Med Care 2007 1.15
79 A comparison of two approaches to text processing: facilitating chart reviews of radiology reports in electronic medical records. Perspect Health Inf Manag 2010 1.14
80 CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation? AIDS Res Ther 2010 1.13
81 HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction. J Acquir Immune Defic Syndr 2015 1.13
82 Intoxication before intercourse and risky sexual behavior in male veterans with and without human immunodeficiency virus infection. Med Care 2006 1.13
83 Health-related quality of life in veterans and nonveterans with HIV/AIDS. J Gen Intern Med 2006 1.13
84 Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. J Infect Dis 2011 1.11
85 Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics. Int J Epidemiol 2012 1.11
86 HIV infection, aging, and immune function: implications for cancer risk and prevention. Curr Opin Oncol 2012 1.10
87 Refill adherence to oral hypoglycemic agents and glycemic control in veterans. Ann Pharmacother 2010 1.10
88 Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection. Drug Alcohol Depend 2011 1.10
89 Systematic cultural adaptation of cognitive-behavioral therapy to reduce alcohol use among HIV-infected outpatients in western Kenya. AIDS Behav 2010 1.10
90 Estimating alcohol content of traditional brew in Western Kenya using culturally relevant methods: the case for cost over volume. AIDS Behav 2008 1.09
91 Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. Clin Infect Dis 2014 1.06
92 Personal health record use and its association with antiretroviral adherence: survey and medical record data from 1871 US veterans infected with HIV. AIDS Behav 2013 1.05
93 Quantifying the decrement in utility from perceived side effects of combination antiretroviral therapies in patients with HIV. Value Health 2008 1.03
94 Receipt of opioid analgesics by HIV-infected and uninfected patients. J Gen Intern Med 2012 1.02
95 The association between the receipt of lipid lowering therapy and HIV status among veterans who met NCEP/ATP III criteria for the receipt of lipid lowering medication. J Gen Intern Med 2009 1.02
96 Comparing alcohol screening measures among HIV-infected and -uninfected men. Alcohol Clin Exp Res 2012 1.01
97 Incorporating quality of evidence into decision analytic modeling. Ann Intern Med 2007 1.01
98 Hepatitis C and the risk of kidney disease and mortality in veterans with HIV. J Acquir Immune Defic Syndr 2010 1.01
99 Increased risk of radiographic emphysema in HIV is associated with elevated soluble CD14 and nadir CD4. Chest 2014 1.00
100 FIB-4 index is associated with hepatocellular carcinoma risk in HIV-infected patients. Cancer Epidemiol Biomarkers Prev 2011 1.00
101 Antiretroviral therapy reduces the rate of hepatic decompensation among HIV- and hepatitis C virus-coinfected veterans. Clin Infect Dis 2013 1.00
102 Patient-reported symptoms on the antiretroviral regimen efavirenz/emtricitabine/tenofovir. AIDS Patient Care STDS 2012 1.00
103 Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort Study. J Acquir Immune Defic Syndr 2012 0.98
104 Erectile dysfunction drug receipt, risky sexual behavior and sexually transmitted diseases in HIV-infected and HIV-uninfected men. J Gen Intern Med 2009 0.97
105 Agreement between electronic medical record-based and self-administered pain numeric rating scale: clinical and research implications. Med Care 2013 0.97
106 Nonmedical use of prescription opioids and pain in veterans with and without HIV. Pain 2011 0.97
107 Comparison of two VA laboratory data repositories indicates that missing data vary despite originating from the same source. Med Care 2009 0.97
108 Associations between alcohol use and homelessness with healthcare utilization among human immunodeficiency virus-infected veterans. Med Care 2006 0.97
109 Women at war: understanding how women veterans cope with combat and military sexual trauma. Soc Sci Med 2011 0.96
110 Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone. Alcohol Clin Exp Res 2011 0.92
111 Critical illness in HIV-infected patients in the era of combination antiretroviral therapy. Proc Am Thorac Soc 2011 0.92
112 Factors associated with dementia and cognitive impairments in veterans with human immunodeficiency virus. Arch Neurol 2002 0.92
113 Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy. J Acquir Immune Defic Syndr 2015 0.91
114 Validation of an algorithm to identify antiretroviral-naïve status at time of entry into a large, observational cohort of HIV-infected patients. Pharmacoepidemiol Drug Saf 2013 0.91
115 Unhealthy alcohol and illicit drug use are associated with decreased quality of HIV care. J Acquir Immune Defic Syndr 2012 0.90
116 Prehypertension, hypertension, and the risk of acute myocardial infarction in HIV-infected and -uninfected veterans. Clin Infect Dis 2013 0.90
117 Does social isolation predict hospitalization and mortality among HIV+ and uninfected older veterans? J Am Geriatr Soc 2013 0.89
118 A comparison of treatment eligibility for hepatitis C virus in HCV-monoinfected versus HCV/HIV-coinfected persons in electronically retrieved cohort of HCV-infected veterans. AIDS Res Hum Retroviruses 2011 0.88
119 Factor structure of Leigh's (1990) alcohol sex expectancies scale in individuals in treatment for HIV disease. AIDS Behav 2008 0.88
120 An adapted frailty-related phenotype and the VACS index as predictors of hospitalization and mortality in HIV-infected and uninfected individuals. J Acquir Immune Defic Syndr 2014 0.88
121 Long-term Prescription of Opioids and/or Benzodiazepines and Mortality Among HIV-Infected and Uninfected Patients. J Acquir Immune Defic Syndr 2015 0.86
122 Development of an electronic medical record-based clinical decision support tool to improve HIV symptom management. AIDS Patient Care STDS 2009 0.86
123 A study of financial incentives to reduce plasma HIV RNA among patients in care. AIDS Behav 2013 0.86
124 Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration. J Acquir Immune Defic Syndr 2015 0.85
125 Evaluating interventions to improve antiretroviral adherence: how much of an effect is required for favorable value? Value Health 2010 0.85
126 Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV Treatment. J Acquir Immune Defic Syndr 2016 0.85
127 Association of the veterans aging cohort study index with exercise capacity in HIV-infected adults. AIDS Res Hum Retroviruses 2013 0.84
128 Sex disparities in overall burden of disease among HIV-infected individuals in the Veterans Affairs healthcare system. J Gen Intern Med 2013 0.83
129 Time trends in cancer incidence in persons living with HIV/AIDS in the antiretroviral therapy era: 1997-2012. AIDS 2016 0.82
130 HIV infection, antiretroviral therapy initiation and longitudinal changes in biomarkers of organ function. Curr HIV Res 2014 0.82
131 The musculoskeletal diagnosis cohort: examining pain and pain care among veterans. Pain 2016 0.81
132 Time to depression treatment in primary care among HIV-infected and uninfected veterans. J Gen Intern Med 2010 0.81
133 The VACS index predicts mortality in a young, healthy HIV population starting highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2014 0.81
134 Leaky pipes, Faustian dilemmas, and a room of one's own: can we build a more flexible pipeline to academic success? Ann Intern Med 2009 0.81
135 Fracture Prediction With Modified-FRAX in Older HIV-Infected and Uninfected Men. J Acquir Immune Defic Syndr 2016 0.80
136 Comparison of outpatient health care utilization among returning women and men veterans from Afghanistan and Iraq. BMC Health Serv Res 2010 0.80
137 Decreased serum antibody responses to recombinant pneumocystis antigens in HIV-infected and uninfected current smokers. Clin Vaccine Immunol 2010 0.80
138 Can broader diffusion of value-based insurance design increase benefits from US health care without increasing costs? Evidence from a computer simulation model. PLoS Med 2010 0.79
139 Measuring alcohol consumption using Timeline Followback in non-treatment-seeking medical clinic patients with and without HIV infection: 7-, 14-, or 30-day recall. J Stud Alcohol Drugs 2013 0.79
140 A polymorphism in the leptin gene promoter is associated with anemia in patients with HIV disease. Blood 2011 0.78
141 Determinants of hormone therapy discontinuation among female veterans nationally. Mil Med 2008 0.78
142 Evaluation of multiple failure time analyses of observational data in patients treated for HIV. HIV Clin Trials 2005 0.78
143 When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational Study. J Acquir Immune Defic Syndr 2016 0.78
144 Weight Gain and Incident Diabetes Among HIV-Infected Veterans Initiating Antiretroviral Therapy Compared With Uninfected Individuals. J Acquir Immune Defic Syndr 2016 0.78
145 Algorithm for assessing patients' adherence to oral hypoglycemic medication. Am J Health Syst Pharm 2005 0.77
146 Incarceration and health outcomes in HIV-infected patients: the impact of substance use, primary care engagement, and antiretroviral adherence. Am J Addict 2015 0.77
147 Depression symptoms and treatment among HIV infected and uninfected veterans. AIDS Behav 2008 0.77
148 Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared to the General Population. J Acquir Immune Defic Syndr 2017 0.76
149 Association of chronic obstructive pulmonary disease with frailty measurements in HIV-infected and uninfected Veterans. AIDS 2016 0.76
150 Disparities in rates of spine surgery for degenerative spine disease between HIV-infected and uninfected veterans. Spine (Phila Pa 1976) 2012 0.76
151 Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People? J Acquir Immune Defic Syndr 2016 0.76
152 Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People? J Acquir Immune Defic Syndr 2016 0.76
153 Primary care of women aging with HIV. J Midwifery Womens Health 2015 0.75
154 Sleep Disturbance Among HIV Infected and Uninfected Veterans. J Acquir Immune Defic Syndr 2016 0.75
155 Identification of HIV infection-related DNA methylation sites and advanced epigenetic aging in HIV+, treatment-naïve U.S. veterans. AIDS 2016 0.75
156 Does Clinical Inertia Vary According to Provider Type? Fed Pract 2008 0.75
157 Acetaminophen receipt among HIV-infected patients with advanced hepatic fibrosis. Pharmacoepidemiol Drug Saf 2013 0.75
158 HIV and ageing: improving quantity and quality of life. Curr Opin HIV AIDS 2016 0.75
159 The Effect of Substance Use Disorders on the Association Between Guideline-concordant Long-term Opioid Therapy and All-cause Mortality. J Addict Med 2016 0.75
160 Isolated Hepatitis B Core Antibody is Associated With Advanced Hepatic Fibrosis in HIV/HCV Infection But Not in HIV Infection Alone. J Acquir Immune Defic Syndr 2016 0.75
161 Associations of CD4+ T-cell count, HIV-1 RNA viral load, and antiretroviral therapy with Kaposi sarcoma risk among HIV-infected persons in the United States and Canada. J Acquir Immune Defic Syndr 2017 0.75
162 Trajectories of Sleep Disturbance Severity in HIV-Infected and Uninfected Veterans. J Assoc Nurses AIDS Care 2017 0.75
163 Ten-year trends in anti-retroviral therapy persistence among US medicaid beneficiaries, 2001-2010. AIDS 2017 0.75
164 Mental illness and homelessness among veterans. Psychiatr Serv 2011 0.75
165 Ten-year trends in antiretroviral therapy persistence among US Medicaid beneficiaries. AIDS 2017 0.75
166 HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer. J Acquir Immune Defic Syndr 2017 0.75
167 Long-term alcohol use patterns and HIV disease severity. AIDS 2017 0.75
168 Long-term alcohol use patterns and HIV disease severity: A joint trajectory analysis. AIDS 2017 0.75
169 Collection of socially sensitive data: A randomized study comparing the advantages and limitations of self administered questionnaire on computer vs. traditional paper based method. AMIA Annu Symp Proc 2007 0.75
170 SARS-CoV-2 testing and positivity among persons with and without HIV in 6 United States cohorts. J Acquir Immune Defic Syndr 2022 0.75